Paediatric tuberculosis in Queensland, Australia: overrepresentation of cross-border and Indigenous children

Int J Tuberc Lung Dis. 2017 Mar 1;21(3):263-269. doi: 10.5588/ijtld.16.0313.

Abstract

Setting: Queensland, Australia.

Background: Understanding paediatric tuberculosis (TB) is important, as children with TB typically reflect recent community transmission. Children pose unique diagnostic challenges and are at risk of developing severe disseminated infection.

Objective: To describe the epidemiology, presentation and outcomes of children with TB disease in Queensland.

Design: This is a retrospective case series of children diagnosed with TB aged 0-16 years notified in 2005-2014. Data collected in the Queensland Notifiable Conditions System were extracted and analysed.

Results: Of 127 children diagnosed with TB, 16 were Australian-born (including 12 Indigenous Queenslanders), 41 were overseas-born permanent and temporary residents and 70 were cross-border Papua New Guinea (PNG) children; 88 children had pulmonary disease (with/without other sites) and 39 had extra-pulmonary disease only, with lymph node TB the predominant extra-pulmonary site; 70.1% of children had laboratory confirmation; and 14 cross-border children had multidrug-resistant TB. Treatment outcomes among children residing in Australia were good (100% among Australian-born and 97.2% among permanent and temporary residents), but they were less favourable among PNG children diagnosed in the Torres Strait Protected Zone (76.6%).

Conclusion: Queensland has unique challenges in TB control, with a high proportion of cross-border diagnoses and over-representation of Indigenous children. Vigilance is needed given the wide spectrum of clinical presentation, particularly in high-risk communities.

MeSH terms

  • Adolescent
  • Antitubercular Agents / administration & dosage*
  • Child
  • Child, Preschool
  • Emigrants and Immigrants / statistics & numerical data
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Polymerase Chain Reaction
  • Queensland / epidemiology
  • Retrospective Studies
  • Treatment Outcome
  • Tuberculosis, Lymph Node / drug therapy
  • Tuberculosis, Lymph Node / epidemiology*
  • Tuberculosis, Lymph Node / ethnology
  • Tuberculosis, Multidrug-Resistant / drug therapy
  • Tuberculosis, Multidrug-Resistant / epidemiology*
  • Tuberculosis, Multidrug-Resistant / ethnology
  • Tuberculosis, Pulmonary / drug therapy
  • Tuberculosis, Pulmonary / epidemiology*
  • Tuberculosis, Pulmonary / ethnology

Substances

  • Antitubercular Agents